Search results
Results from the WOW.Com Content Network
Use of glimepiride is recommended in conjunction with lifestyle modifications such as diet and exercise. [1] It is taken by mouth, [1] reaching a peak effect within three hours and lasting for about a day. [1] Common side effects include headache, nausea, and dizziness. [1] Serious side effects may include low blood sugar. [1]
The American Association of Clinical Endocrinologists (AACE), which provides clinical practice guidelines for management of diabetes, retains thiazolidinediones as recommended first, second, or third line agents for type 2 diabetes mellitus, as of their 2019 executive summary, over sulfonylureas and α-glucosidase inhibitors.
[2] [1] It contains the thiazolidinedione pioglitazone and the sulfonylurea glimepiride. [2] [1] It is taken by mouth. [2] [1] The most common side effects include upper respiratory tract infections (such as colds), hypoesthesia (reduced sense of touch), bone fractures, weight gain, dizziness, flatulence (gas) and edema (swelling). [1]
·No dose adjustment is recommended for patients with renal or hepatic impairment. ·Gemigliptin shows a low propensity of drug interactions with metformin, pioglitazone, glimepiride, CYP3A4 inhibitors, rosuvastatin, or irbesartan, and dose adjustment of gemigliptin is not required for the patients who are concomitantly receiving these drugs.
At the same time, we get that overeating can come with some uncomfortable side effects, like bloating. That’s why we’re here to help. We’ll cover one of the easiest things you can do to help ...
In those already taking sulphonylureas, there is an increased risk of low blood sugar when taking a medicine in the DPP-4 drug class. [19]Adverse effects include nasopharyngitis, headache, nausea, heart failure, hypersensitivity and skin reactions.
UBS recommends tech, financials, industrials and utilities stocks going into 2025, citing continued AI growth and pro-business policies under Trump.
From 1999 to 2020, the number of alcohol-related deaths has nearly doubled, according to Florida Atlantic University study. A researcher and addiction specialists discuss the risk factors.